Literature DB >> 2817580

Compliance with isoniazid prophylaxis in jail.

P Alcabes1, P Vossenas, R Cohen, C Braslow, D Michaels, S Zoloth.   

Abstract

The incidence of tuberculosis in New York City has risen dramatically in the last decade, an increase that has also been seen in the incarcerated population on Rikers Island, New York City's principal jail. We have investigated the establishment and maintenance of compliance with isoniazid prophylaxis in this population. Factors affecting compliance were studied in a sample of young men who were found to be tubercullin-reactive at the time of their incarceration. Compliance was quantified by determining the number of doses taken divided by the total number of available doses. Mean compliance for the 74 subjects was 37.5%. Two factors were important determinants of compliance: (1) the building where the inmate was incarcerated and (2) his knowledge of tuberculoses and the isoniazed regimen. The influence of the housing unit on compliance suggests that administrative responses to prison overcrowding, an increasingly prevalent condition in the nation's jails and prisons, may have an unintended and detrimental effect on medical care and public health.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2817580     DOI: 10.1164/ajrccm/140.5.1194

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  8 in total

1.  Screening for tuberculosis in jail and clinic follow-up after release.

Authors:  J P Tulsky; M C White; C Dawson; T M Hoynes; J Goldenson; G Schecter
Journal:  Am J Public Health       Date:  1998-02       Impact factor: 9.308

2.  An unanswered health disparity: tuberculosis among correctional inmates, 1993 through 2003.

Authors:  Jessica R MacNeil; Mark N Lobato; Marisa Moore
Journal:  Am J Public Health       Date:  2005-10       Impact factor: 9.308

3.  Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community.

Authors:  J Lorvick; S Thompson; B R Edlin; A H Kral; A R Lifson; J K Watters
Journal:  J Urban Health       Date:  1999-12       Impact factor: 3.671

4.  Fatal isoniazid-induced hepatitis. Its risk during chemoprophylaxis.

Authors:  S R Salpeter
Journal:  West J Med       Date:  1993-11

5.  Tuberculosis knowledge among New York City injection drug users.

Authors:  H Wolfe; M Marmor; R Maslansky; S Nichols; M Simberkoff; D Des Jarlais; A Moss
Journal:  Am J Public Health       Date:  1995-07       Impact factor: 9.308

6.  Predictors of adherence to isoniazid preventive therapy among HIV positive adults in Addis Ababa, Ethiopia.

Authors:  Mesele Mindachew; Amare Deribew; Fasil Tessema; Sibhatu Biadgilign
Journal:  BMC Public Health       Date:  2011-12-12       Impact factor: 3.295

7.  A situational analysis of latent tuberculosis infection among incarcerated population in Japan.

Authors:  Lisa Kawatsu; Kazuhiro Uchimura; Akihiro Ohkado
Journal:  PLoS One       Date:  2018-09-07       Impact factor: 3.240

8.  Beyond pills and tests: addressing the social determinants of tuberculosis.

Authors:  Tom Wingfield; Marco A Tovar; Doug Huff; Delia Boccia; Matthew J Saunders; Sumona Datta; Rosario Montoya; Eric Ramos; James J Lewis; Robert H Gilman; Carlton Evans
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.